WO1996005192A1 - Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof - Google Patents

Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof Download PDF

Info

Publication number: WO1996005192A1
Authority: WO; WIPO (PCT)
Prior art keywords: salt; acid derivative; optionally substituted; hydrogen; lower alkyl
Prior art date: 1994-08-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

PCT/JP1995/001551

Other languages

English (en)

French (fr)

Inventor

Yozo Todo

Kazuya Hayashi

Masahiro Takahata

Yasuo Watanabe

Hirokazu Narita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Toyama Chemical Co Ltd

Original Assignee

Toyama Chemical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-12

Filing date

1995-08-04

Publication date

1996-02-22

1995-08-04 Priority to JP8507180A priority Critical patent/JP2994759B2/ja

1995-08-04 Priority to US08/776,711 priority patent/US5935952A/en

1995-08-04 Priority to EP95927967A priority patent/EP0775702B1/en

1995-08-04 Priority to DK95927967T priority patent/DK0775702T3/da

1995-08-04 Priority to AU31906/95A priority patent/AU692583B2/en

1995-08-04 Priority to CA002196271A priority patent/CA2196271C/en

1995-08-04 Priority to AT95927967T priority patent/ATE245638T1/de

1995-08-04 Priority to DE69531350T priority patent/DE69531350T2/de

1995-08-04 Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd

1995-08-04 Priority to NZ290946A priority patent/NZ290946A/en

1995-08-04 Priority to HU9701734A priority patent/HU228062B1/hu

1996-02-22 Publication of WO1996005192A1 publication Critical patent/WO1996005192A1/ja

1997-02-11 Priority to NO19970622A priority patent/NO312032B1/no

1997-02-11 Priority to FI970578A priority patent/FI113652B/fi

1997-02-12 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PCT/JP1995/001551 1994-08-12 1995-08-04 Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof Ceased WO1996005192A1 (en)

Priority Applications (12)

Application Number	Priority Date	Filing Date	Title
AT95927967T ATE245638T1 (de)	1994-08-12	1995-08-04	Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze
EP95927967A EP0775702B1 (en)	1994-08-12	1995-08-04	Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
DK95927967T DK0775702T3 (da)	1994-08-12	1995-08-04	Hidtil ukendte quinolon- eller naphthylidoncarboxylsyrederivater eller salt deraf
AU31906/95A AU692583B2 (en)	1994-08-12	1995-08-04	Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
CA002196271A CA2196271C (en)	1994-08-12	1995-08-04	Quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
DE69531350T DE69531350T2 (de)	1994-08-12	1995-08-04	Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze
NZ290946A NZ290946A (en)	1994-08-12	1995-08-04	Quinolone- or naphthyridone-carboxylic acid derivatives
JP8507180A JP2994759B2 (ja)	1994-08-12	1995-08-04	新規なキノロン−またはナフチリドン−カルボン酸誘導体もしくはそれらの塩
US08/776,711 US5935952A (en)	1994-08-12	1995-08-04	Quinolone- or naphthylidone-carboxylic acid derivates or their salts
HU9701734A HU228062B1 (en)	1994-08-12	1995-08-04	Quinolone- carboxylic acid derivative and salt thereof
NO19970622A NO312032B1 (no)	1994-08-12	1997-02-11	Nye kinolon- eller naftylidonkarboksylsyre-derivater eller salter derav samt anvendelse derav
FI970578A FI113652B (fi)	1994-08-12	1997-02-11	Uusia kinoloni- tai naftyridonikarboksyylihappojohdannaisia tai niiden suola

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP21208394		1994-08-12
JP6/212083		1994-08-12

Publications (1)

Publication Number	Publication Date
WO1996005192A1 true WO1996005192A1 (en)	1996-02-22

Family

ID=16616594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/JP1995/001551 Ceased WO1996005192A1 (en)	1994-08-12	1995-08-04	Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof

Country Status (17)

Country	Link
US (1)	US5935952A (ja)
EP (1)	EP0775702B1 (ja)
KR (1)	KR100371723B1 (ja)
CN (1)	CN1070191C (ja)
AT (1)	ATE245638T1 (ja)
AU (1)	AU692583B2 (ja)
CA (1)	CA2196271C (ja)
DE (1)	DE69531350T2 (ja)
DK (1)	DK0775702T3 (ja)
ES (1)	ES2203644T3 (ja)
FI (1)	FI113652B (ja)
HU (1)	HU228062B1 (ja)
IL (1)	IL114875A (ja)
NO (1)	NO312032B1 (ja)
NZ (1)	NZ290946A (ja)
WO (1)	WO1996005192A1 (ja)
ZA (1)	ZA956713B (ja)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997029102A1 (en) *	1996-02-09	1997-08-14	Toyama Chemical Co., Ltd.	Quinolonecarboxylic acid derivatives or salts thereof
WO1999007682A1 (en) *	1997-08-08	1999-02-18	Toyama Chemical Co., Ltd.	Quinolonecarboxylic acid derivatives or salts thereof
WO1999021849A1 (en) *	1997-10-27	1999-05-06	Toyama Chemical Co., Ltd.	Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient
US6011046A (en) *	1995-08-21	2000-01-04	Takeda Chemical Industries, Ltd.	Quinone compound, its production and use as antioxidant
JP2000143631A (ja) *	1998-08-31	2000-05-26	Toyama Chem Co Ltd	７−ブロモ−キノロンカルボン酸誘導体の製造法
WO2000046223A1 (en) *	1999-02-05	2000-08-10	Toyama Chemical Co., Ltd.	Tricyclic quinolonecarboxylic acid derivatives or salts thereof
WO2001066542A1 (en) *	2000-03-10	2001-09-13	Dainippon Pharmaceutical Co., Ltd.	Pyridonecarboxylic acid derivatives
JP2006504620A (ja) *	2002-03-12	2006-02-09	ブリストル−マイヤーズ　スクイブ　カンパニー	快い味の経口懸濁液および方法
JP2006206595A (ja) *	2001-04-19	2006-08-10	Eisai Co Ltd	２−イミノピロリジン誘導体
JP2008031090A (ja) *	2006-07-28	2008-02-14	Toyota Central Res & Dev Lab Inc	有機スズ化合物及びその製造方法、並びに芳香族化合物誘導体の製造方法
US7375236B2 (en)	2003-02-19	2008-05-20	Eisai Co., Ltd.	Methods for producing cyclic benzamidine derivatives
CN101298418B (zh) *	2008-06-13	2010-12-15	江苏康鹏农化有限公司	3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
JP2017039733A (ja) *	2011-08-31	2017-02-23	大塚製薬株式会社	キノロン化合物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY138335A (en)	1997-09-15	2009-05-29	Procter & Gamble	Antimicrobial quinolones, their compositions and uses
WO2001029035A1 (en)	1999-10-19	2001-04-26	Sato Pharmaceutical Co., Ltd.	4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure
JP4751557B2 (ja)	2000-03-07	2011-08-17	富山化学工業株式会社	抗菌キノロン薬のための有用な中間物としてのアルキル３−シクロプロピルアミノ−２−［２，４−ジブロモ−３−（ジフルオロメトキシ）ベンゾイル］−２−プロペノエートのワンポット合成法
US6525049B2 (en)	2000-07-05	2003-02-25	Pharmacia & Upjohn Company	Pyrroloquinolones as antiviral agents
AU2001276748A1 (en) *	2000-08-08	2002-02-18	Daiichi Pharmaceutical Co., Ltd.	Highly absorbable solid preparation
IL155678A0 (en)	2000-12-14	2003-11-23	Procter & Gamble	Antimicrobial 2-pyridones, their compositions and uses
DK1341781T3 (da)	2000-12-14	2005-12-05	Procter & Gamble	Antimikrobielle quinoloner
CA2647454A1 (en)	2006-03-28	2007-10-04	The Procter & Gamble Company	A coupling process for preparing quinolone intermediates
DK2001862T3 (da)	2006-03-28	2011-08-08	Warner Chilcott Co Llc	Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
CN102212056A (zh) *	2010-04-09	2011-10-12	山东轩竹医药科技有限公司	新的双环喹诺酮类化合物
CA2904387C (en)	2013-03-15	2021-12-07	Melinta Therapeutics, Inc.	Methods of treating infections in overweight and obese patients using antibiotics

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61143365A (ja) *	1984-12-06	1986-07-01	フアイザー・インコーポレーテツド	置換ジヒドロキノロンカルボン酸
JPH01319463A (ja) *	1988-05-11	1989-12-25	Bayer Ag	７―置換キノロン―及びナフチリドン―カルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3248507A1 (de) *	1982-12-29	1984-07-05	Bayer Ag, 5090 Leverkusen	Mikrobizide mittel auf chinoloncarbonsaeure basis
JPH0262875A (ja) *	1988-05-23	1990-03-02	Wakunaga Pharmaceut Co Ltd	新規イソインドリン誘導体
US4945160A (en) *	1988-11-22	1990-07-31	Warner-Lambert Company	Preparation of certain 7-substituted quinolones

1995
- 1995-08-04 AT AT95927967T patent/ATE245638T1/de active
- 1995-08-04 AU AU31906/95A patent/AU692583B2/en not_active Expired
- 1995-08-04 WO PCT/JP1995/001551 patent/WO1996005192A1/ja not_active Ceased
- 1995-08-04 NZ NZ290946A patent/NZ290946A/en not_active IP Right Cessation
- 1995-08-04 DK DK95927967T patent/DK0775702T3/da active
- 1995-08-04 HU HU9701734A patent/HU228062B1/hu unknown
- 1995-08-04 CA CA002196271A patent/CA2196271C/en not_active Expired - Lifetime
- 1995-08-04 CN CN95195310A patent/CN1070191C/zh not_active Expired - Lifetime
- 1995-08-04 US US08/776,711 patent/US5935952A/en not_active Expired - Lifetime
- 1995-08-04 DE DE69531350T patent/DE69531350T2/de not_active Expired - Lifetime
- 1995-08-04 EP EP95927967A patent/EP0775702B1/en not_active Expired - Lifetime
- 1995-08-04 ES ES95927967T patent/ES2203644T3/es not_active Expired - Lifetime
- 1995-08-04 KR KR1019970700919A patent/KR100371723B1/ko not_active Expired - Lifetime
- 1995-08-08 IL IL11487595A patent/IL114875A/xx not_active IP Right Cessation
- 1995-08-11 ZA ZA956713A patent/ZA956713B/xx unknown
1997
- 1997-02-11 NO NO19970622A patent/NO312032B1/no not_active IP Right Cessation
- 1997-02-11 FI FI970578A patent/FI113652B/fi not_active IP Right Cessation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61143365A (ja) *	1984-12-06	1986-07-01	フアイザー・インコーポレーテツド	置換ジヒドロキノロンカルボン酸
JPH01319463A (ja) *	1988-05-11	1989-12-25	Bayer Ag	７―置換キノロン―及びナフチリドン―カルボン酸誘導体

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6011046A (en) *	1995-08-21	2000-01-04	Takeda Chemical Industries, Ltd.	Quinone compound, its production and use as antioxidant
WO1997029102A1 (en) *	1996-02-09	1997-08-14	Toyama Chemical Co., Ltd.	Quinolonecarboxylic acid derivatives or salts thereof
WO1999007682A1 (en) *	1997-08-08	1999-02-18	Toyama Chemical Co., Ltd.	Quinolonecarboxylic acid derivatives or salts thereof
WO1999021849A1 (en) *	1997-10-27	1999-05-06	Toyama Chemical Co., Ltd.	Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient
JP2000143631A (ja) *	1998-08-31	2000-05-26	Toyama Chem Co Ltd	７−ブロモ−キノロンカルボン酸誘導体の製造法
WO2000046223A1 (en) *	1999-02-05	2000-08-10	Toyama Chemical Co., Ltd.	Tricyclic quinolonecarboxylic acid derivatives or salts thereof
WO2001066542A1 (en) *	2000-03-10	2001-09-13	Dainippon Pharmaceutical Co., Ltd.	Pyridonecarboxylic acid derivatives
JP2006206595A (ja) *	2001-04-19	2006-08-10	Eisai Co Ltd	２−イミノピロリジン誘導体
US7244730B2 (en)	2001-04-19	2007-07-17	Eisai Co., Ltd	2-iminopyrrolidine derivatives
US7304083B2 (en)	2001-04-19	2007-12-04	Eisai R&D Management Co., Ltd.	2-iminoimidazole derivatives (2)
US7476688B2 (en)	2001-04-19	2009-01-13	Eisai R&D Management Co., Ltd.	Cyclic amidine derivatives
JP2006504620A (ja) *	2002-03-12	2006-02-09	ブリストル−マイヤーズ　スクイブ　カンパニー	快い味の経口懸濁液および方法
US7375236B2 (en)	2003-02-19	2008-05-20	Eisai Co., Ltd.	Methods for producing cyclic benzamidine derivatives
JP2008031090A (ja) *	2006-07-28	2008-02-14	Toyota Central Res & Dev Lab Inc	有機スズ化合物及びその製造方法、並びに芳香族化合物誘導体の製造方法
CN101298418B (zh) *	2008-06-13	2010-12-15	江苏康鹏农化有限公司	3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
JP2017039733A (ja) *	2011-08-31	2017-02-23	大塚製薬株式会社	キノロン化合物
JP2018150324A (ja) *	2011-08-31	2018-09-27	大塚製薬株式会社	キノロン化合物

Also Published As

Publication number	Publication date
AU3190695A (en)	1996-03-07
NO312032B1 (no)	2002-03-04
FI970578A0 (fi)	1997-02-11
AU692583B2 (en)	1998-06-11
KR970704728A (ko)	1997-09-06
CN1158611A (zh)	1997-09-03
ES2203644T3 (es)	2004-04-16
EP0775702A1 (en)	1997-05-28
EP0775702B1 (en)	2003-07-23
NO970622L (no)	1997-04-10
FI970578L (fi)	1997-04-10
IL114875A (en)	1999-12-22
HU228062B1 (en)	2012-09-28
CA2196271C (en)	2007-01-09
NO970622D0 (no)	1997-02-11
ATE245638T1 (de)	2003-08-15
EP0775702A4 (en)	1997-11-05
DE69531350T2 (de)	2004-05-27
DK0775702T3 (da)	2003-08-18
HUT77314A (hu)	1998-03-30
IL114875A0 (en)	1995-12-08
NZ290946A (en)	1997-12-19
DE69531350D1 (de)	2003-08-28
KR100371723B1 (ko)	2003-03-15
ZA956713B (en)	1996-03-28
FI113652B (fi)	2004-05-31
CA2196271A1 (en)	1996-02-22
US5935952A (en)	1999-08-10
CN1070191C (zh)	2001-08-29

Publication	Publication Date	Title
WO1996005192A1 (en)	1996-02-22	Novel quinolone- or naphthyridonecarboxylic acid derivative or salt thereof
EP0703902A4 (ja)	1996-04-10
TW370450B (en)	1999-09-21	Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
CA2173150A1 (en)	1995-04-13	Novel peptide derivatives
EP0513387A4 (en)	1993-04-21	Active oxygen inhibitor
NZ330656A (en)	1999-06-29	Tricyclic compounds, their production and use
EP0979821A4 (en)	2002-04-24	TRICYCLIC CONNECTIONS
WO1999000373A8 (en)	2000-07-20	Benzimidazole derivatives
AU7332696A (en)	1997-05-07	Triciclic compounds
AU7824900A (en)	2001-04-23	Compounds and methods for inhibiting mrp1
AU628521B2 (en)	1992-09-17	Improvements in or relating to organic compounds
BR0313566A (pt)	2005-06-21	Composto de 4-nitroimidazol 1-substituìdo, método para preparar um composto de 4-nitroimidazol, método para preparar um composto de 4-nitroimidazol 1-substituìdo, derivado de 4-nitroimidazol, e, composto
CA2226406A1 (en)	1994-07-21	Novel pyridone carboxylic acid derivatives
CA2168563A1 (en)	1995-02-16	Benzopyrans and Pharmaceutical Compositions Containing Them
AU4459296A (en)	1996-08-14	2-substituted vitamin d3 derivatives
GB9325618D0 (en)	1994-02-16	New herbicides
EP0394471A4 (en)	1991-12-18	Thienocycloheptapyridazine compounds and medicinal uses thereof
UA80839C2 (en)	2007-11-12	1-substituted 4-nitroimidazole compound and process for producing the same
AU5715894A (en)	1994-07-19	Methotrexate derivative
EP0787732A3 (en)	1998-10-14	Phthalocyanines
WO1998034584A3 (en)	1998-11-19	Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
WO2003044877A3 (en)	2003-10-30	Light emitting device and compounds for use therein
AU6730600A (en)	2001-03-26	Vitamin d derivatives having substituents at the 2alpha-position
CA2224618A1 (en)	1998-06-30	Organic pigment compositions
EP1057824A4 (en)	2002-01-09	METHOD FOR PRODUCING OPTICALLY ACTIVE CHROME DERIVATIVES

Legal Events

Date	Code	Title	Description
1995-08-04	WWE	Wipo information: entry into national phase	Ref document number: 95195310.9 Country of ref document: CN
1996-02-22	AK	Designated states	Kind code of ref document: A1 Designated state(s): AU CA CN FI HU JP KR NO NZ US
1996-02-22	AL	Designated countries for regional patents	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE
1996-06-05	121	Ep: the epo has been informed by wipo that ep was designated in this application
1996-08-15	DFPE	Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
1997-01-29	WWE	Wipo information: entry into national phase	Ref document number: 2196271 Country of ref document: CA
1997-02-03	WWE	Wipo information: entry into national phase	Ref document number: 1995927967 Country of ref document: EP
1997-02-10	WWE	Wipo information: entry into national phase	Ref document number: 290946 Country of ref document: NZ
1997-02-11	WWE	Wipo information: entry into national phase	Ref document number: 970578 Country of ref document: FI
1997-02-12	WWE	Wipo information: entry into national phase	Ref document number: 1019970700919 Country of ref document: KR Ref document number: 08776711 Country of ref document: US
1997-05-28	WWP	Wipo information: published in national office	Ref document number: 1995927967 Country of ref document: EP
1997-09-06	WWP	Wipo information: published in national office	Ref document number: 1019970700919 Country of ref document: KR
2002-10-28	WWG	Wipo information: grant in national office	Ref document number: 1019970700919 Country of ref document: KR
2003-07-23	WWG	Wipo information: grant in national office	Ref document number: 1995927967 Country of ref document: EP
2004-05-31	WWG	Wipo information: grant in national office	Ref document number: 970578 Country of ref document: FI